CD14 and acute myeloid leukemia: Aligned with this observation, analysis of the BEAT AML dataset also noticed higher Venetoclax AUC in the leukemic blasts with high expression of CD14 and CLEA7A (gene encoding CD369) that are usually present in M4/M5 AML, suggesting Venetoclax resistance in AML with myelomonocytic or monocytic differentiation[37].